News & Articles
Selected Filters:
A Collaboration of Giants for Cancer Research
AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics
Engineering a Plastic-Eating Enzyme
Researchers aim to tackle the issue of plastic waste by enhancing pre-existing PETase – a known digestive enzyme for plastic materials
Funding Gift Program Announced for Cancer Research Breakthroughs
The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics
BioAscent Establishes Integrated Drug Discovery Solutions
The new division, led by Dr. Phil Jones, aims to offer a comprehensive drug discovery service to customers
Novel Blood Test for Early Detection of De Vivo Disease
Metafora biosystems receives exceptional reimbursement for the new METAglut1 test to help diagnose De Vivo disease
Modeling Cancers with Repositive PDX Platform
The highly anticipated platform was launched by Repositive at AACR annual meeting
Using NovaSeq 6000 for Ultra-High Throughput Sequencing
Earlham Institute boosts national capability in genomics and single cell analysis with ultra-high throughput sequencing platform from Illumina
BD Unveils Latest Diagnostic Innovations at ECCMID
New Synapsys microbiology informatics solution will be demonstrated at the event
Webinar Highlights: SelectScience Speaks to Leading Experts on the Latest Reversed-Phase Columns for Protein Separation
Learn the impact of column technology design on protein RPLC
Yamaha Motor Exhibits CELL HANDLER at U.S. Cancer Research Conference
Cell picking and imaging system by Yamaha has expanded applicability, including ex vivo tissue picking
D-dimer Testing: An Essential Element in Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Diagnosis
SelectScience to host a free, educational webinar on the rapid diagnosis of venous thromboembolism
Addressing Early Detection of Pancreatic Cancer in Familial Risk Groups
NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study
Winners of the 2018 Scientists’ Choice Awards for Life Sciences Announced at AACR
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research
KEYNOTE -189 Clinical Trial Results Presented at AACR 2018
The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer